Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 05-Jun-23 4:36 PM View:  | Tcr2 Therapeutics Inc. (TCRR) | 01-Jun-23 | Disposition (other) | 4,158,960 | -- | -- | (100%) 4.16M to 0 | |
| 06-Jan-22 4:12 PM View: | Iteos Therapeutics, Inc. (ITOS) | 05-Jan-22 | Market Sale | 18,135 | $42.03 | $762,214.00 | (< 1%) 13.84M to 13.82M | < 1% |
| 06-Jan-22 4:12 PM View: | Iteos Therapeutics, Inc. (ITOS) | 04-Jan-22 | Market Sale | 128,550 | $42.66 | $5,483,840.00 | (< 1%) 13.97M to 13.84M | 2% |
| 07-Dec-21 6:35 PM View: | Iteos Therapeutics, Inc. (ITOS) | 07-Dec-21 | Market Sale (Planned) | 19,456 | $33.22 | $646,401.00 | (< 1%) 26.16M to 26.14M | < 1% |
| 07-Dec-21 6:35 PM View: | Iteos Therapeutics, Inc. (ITOS) | 06-Dec-21 | Market Sale (Planned) | 10,208 | $32.59 | $332,698.00 | (< 1%) 26.17M to 26.16M | (1%) |
| 07-Dec-21 6:35 PM View: | Iteos Therapeutics, Inc. (ITOS) | 03-Dec-21 | Market Sale (Planned) | 20,167 | $34.79 | $701,513.00 | (< 1%) 26.19M to 26.17M | 5% |
| 02-Dec-21 6:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 02-Dec-21 | Market Sale (Planned) | 37,187 | $33.96 | $1,262,790.00 | (< 1%) 20.84M to 20.8M | (3%) |
| 02-Dec-21 6:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 01-Dec-21 | Market Sale (Planned) | 12,395 | $34.28 | $424,872.00 | (< 1%) 20.85M to 20.84M | (2%) |
| 02-Dec-21 6:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 30-Nov-21 | Market Sale (Planned) | 33,937 | $35.09 | $1,190,900.00 | (< 1%) 20.88M to 20.85M | < 1% |
| 30-Nov-21 4:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 29-Nov-21 | Market Sale (Planned) | 10,371 | $34.49 | $357,656.00 | (< 1%) 12.11M to 12.1M | < 1% |
| 30-Nov-21 4:53 PM View: | Iteos Therapeutics, Inc. (ITOS) | 26-Nov-21 | Market Sale (Planned) | 12,674 | $35.75 | $453,110.00 | (< 1%) 12.13M to 12.11M | 4% |
| 24-Nov-21 6:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 24-Nov-21 | Market Sale (Planned) | 36,337 | $36.29 | $1,318,540.00 | (< 1%) 24.69M to 24.65M | |
| 24-Nov-21 6:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Nov-21 | Market Sale (Planned) | 20,004 | $36.22 | $724,449.00 | (< 1%) 24.71M to 24.69M | |
| 24-Nov-21 6:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Nov-21 | Market Sale (Planned) | 21,114 | $37.52 | $792,271.00 | (< 1%) 24.73M to 24.71M | |
| 24-Nov-21 6:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 17-Nov-21 | Disposition (other) | 15,671 | -- | -- | (< 1%) 24.75M to 24.73M | |
| 04-Nov-21 5:37 PM View: | Entrada Therapeutics, Inc. (TRDA) | 02-Nov-21 | Conversion Duplicate | 4,325,780 | -- | -- | 53% 8.14M to 12.47M | |
| 04-Nov-21 5:37 PM View: | Entrada Therapeutics, Inc. (TRDA) | 02-Nov-21 | Private Purchase Duplicate | 100,000 | $20.00 | $2,000,000.00 | < 1% 12.47M to 12.57M | |
| 18-Oct-21 4:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 18-Oct-21 | Market Sale (Planned) | 6,167 | $27.14 | $167,372.00 | (< 1%) 9.43M to 9.42M | (2%) |
| 18-Oct-21 4:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 15-Oct-21 | Market Sale (Planned) | 10,932 | $27.62 | $301,937.00 | (< 1%) 9.44M to 9.43M | < 1% |
| 14-Oct-21 5:27 PM View: | Iteos Therapeutics, Inc. (ITOS) | 14-Oct-21 | Market Sale (Planned) | 27,320 | $27.30 | $745,836.00 | (< 1%) 9.56M to 9.53M | (< 1%) |
| 14-Oct-21 5:27 PM View: | Iteos Therapeutics, Inc. (ITOS) | 13-Oct-21 | Market Sale (Planned) | 20,929 | $27.13 | $567,804.00 | (< 1%) 9.58M to 9.56M | (< 1%) |
| 14-Oct-21 5:27 PM View: | Iteos Therapeutics, Inc. (ITOS) | 12-Oct-21 | Market Sale (Planned) | 8,521 | $27.09 | $230,834.00 | (< 1%) 9.59M to 9.58M | (< 1%) |
| 12-Oct-21 4:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 11-Oct-21 | Market Sale (Planned) | 48,812 | $27.24 | $1,329,640.00 | (< 1%) 9.78M to 9.73M | 2% |
| 12-Oct-21 4:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 08-Oct-21 | Market Sale (Planned) | 2,032 | $27.01 | $54,884.30 | (< 1%) 9.78M to 9.78M | < 1% |
| 12-Oct-21 4:34 PM View: | Iteos Therapeutics, Inc. (ITOS) | 07-Oct-21 | Market Sale (Planned) | 1,149 | $27.00 | $31,023.00 | (< 1%) 9.78M to 9.78M | < 1% |
| 05-Oct-21 4:32 PM View: | Iteos Therapeutics, Inc. (ITOS) | 04-Oct-21 | Market Sale (Planned) | 20,711 | $27.06 | $560,440.00 | (< 1%) 6.56M to 6.54M | 1% |
| 05-Oct-21 4:32 PM View: | Iteos Therapeutics, Inc. (ITOS) | 01-Oct-21 | Market Sale (Planned) | 6,855 | $27.00 | $185,085.00 | (< 1%) 6.57M to 6.56M | 1% |
| 30-Sep-21 5:06 PM View: | Iteos Therapeutics, Inc. (ITOS) | 30-Sep-21 | Market Sale (Planned) | 2,292 | $27.00 | $61,884.00 | (< 1%) 6.58M to 6.58M | (< 1%) |
| 30-Sep-21 5:06 PM View: | Iteos Therapeutics, Inc. (ITOS) | 28-Sep-21 | Market Sale (Planned) | 19,214 | $27.00 | $518,778.00 | (< 1%) 6.6M to 6.58M | (< 1%) |
| 27-Sep-21 5:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 27-Sep-21 | Market Sale (Planned) | 11,625 | $27.09 | $314,921.00 | (< 1%) 13.3M to 13.29M | (< 1%) |
| 27-Sep-21 5:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 24-Sep-21 | Market Sale (Planned) | 4,913 | $27.81 | $136,631.00 | (< 1%) 13.3M to 13.3M | 2% |
| 27-Sep-21 5:51 PM View: | Iteos Therapeutics, Inc. (ITOS) | 23-Sep-21 | Market Sale (Planned) | 36,930 | $27.97 | $1,032,860.00 | (< 1%) 13.34M to 13.3M | 3% |
| 23-Sep-21 10:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 22-Sep-21 | Market Sale (Planned) | 14,294 | $27.54 | $393,657.00 | (< 1%) 6.76M to 6.74M | 1% |
| 23-Sep-21 10:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 21-Sep-21 | Market Sale (Planned) | 19,635 | $27.47 | $539,373.00 | (< 1%) 6.78M to 6.76M | 1% |
| 20-Sep-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 20-Sep-21 | Market Sale (Planned) | 24,303 | $27.49 | $668,008.00 | (< 1%) 13.72M to 13.7M | 1% |
| 20-Sep-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 17-Sep-21 | Market Sale (Planned) | 45,698 | $28.82 | $1,317,020.00 | (< 1%) 13.77M to 13.72M | 6% |
| 20-Sep-21 6:38 PM View: | Iteos Therapeutics, Inc. (ITOS) | 16-Sep-21 | Market Sale (Planned) | 21,253 | $28.47 | $605,073.00 | (< 1%) 13.79M to 13.77M | 5% |
| 16-Sep-21 10:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 15-Sep-21 | Market Sale (Planned) Duplicate | 24,104 | $27.80 | $670,207.00 | (< 1%) 14.03M to 14.01M | 2% |
| 16-Sep-21 10:00 PM View: | Iteos Therapeutics, Inc. (ITOS) | 14-Sep-21 | Market Sale (Planned) Duplicate | 21,561 | $27.58 | $594,703.00 | (< 1%) 14.05M to 14.03M | 2% |
| 13-Sep-21 7:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 13-Sep-21 | Market Sale (Planned) Duplicate | 21,384 | $27.64 | $591,054.00 | (< 1%) 14.24M to 14.22M | 2% |
| 13-Sep-21 7:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 10-Sep-21 | Market Sale (Planned) Duplicate | 13,531 | $28.30 | $382,864.00 | (< 1%) 14.26M to 14.24M | 4% |
| 13-Sep-21 7:01 PM View: | Iteos Therapeutics, Inc. (ITOS) | 09-Sep-21 | Market Sale (Planned) Duplicate | 22,725 | $28.97 | $658,343.00 | (< 1%) 14.28M to 14.26M | 6% |
| 08-Sep-21 7:13 PM View: | Iteos Therapeutics, Inc. (ITOS) | 08-Sep-21 | Market Sale (Planned) Duplicate | 12,092 | $28.65 | $346,413.00 | (< 1%) 14.44M to 14.42M | 5% |
| 08-Sep-21 7:13 PM View: | Iteos Therapeutics, Inc. (ITOS) | 07-Sep-21 | Disposition (other) | 31,340 | -- | -- | (< 1%) 14.5M to 14.47M | |
| 08-Sep-21 7:13 PM View: | Iteos Therapeutics, Inc. (ITOS) | 07-Sep-21 | Market Sale (Planned) | 30,474 | $29.18 | $889,231.00 | (< 1%) 14.47M to 14.44M | 7% |
| 06-May-21 4:20 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Conversion | 3,062,240 | -- | -- | 57% 5.36M to 8.42M | |
| 06-May-21 4:20 PM View: | Werewolf Therapeutics, Inc. (HOWL) | 04-May-21 | Market Purchase | 125,759 | $16.00 | $2,012,140.00 | 1% 8.42M to 8.55M | |
| 15-Apr-21 8:01 PM View: | Harpoon Therapeutics, Inc. (HARP) | 15-Apr-21 | Market Sale (Planned) | 1,052 | $20.49 | $21,555.50 | (< 1%) 16.11M to 16.11M | (< 1%) |
| 15-Apr-21 8:01 PM View: | Harpoon Therapeutics, Inc. (HARP) | 14-Apr-21 | Market Sale (Planned) | 1,671 | $20.77 | $34,713.80 | (< 1%) 16.12M to 16.11M | < 1% |
| 15-Apr-21 8:01 PM View: | Harpoon Therapeutics, Inc. (HARP) | 13-Apr-21 | Market Sale (Planned) | 1,943 | $19.46 | $37,805.80 | (< 1%) 16.12M to 16.12M | (6%) |